FindTrial
Sign In

Luteal phase support following letrozole treatment in women undergoing intrauterine insemination: a multicenter randomized trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524327-53-00
Enrollment
690
Registered
2026-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Clinical pregnancy rate

Detailed description

Live birth rate, Biochemical pregnancy rate, Early pregnancy loss, Fetal miscarriage, Perinatal outcomes: preterm birth, birth weight, congenital malformation, perinatal mortality, Obstetric outcomes: hypertensive disorders of pregnancy, gestational diabetes, postpartum hemorrhage and cesarean section, Hormone levels measured on the day of insemination, mid-luteal phase and ovulation trigger (optional)

Interventions

DRUGCyclogest 400 mg vagitorier

Sponsors

Region Midtjylland
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate—

Secondary

MeasureTime frame
Live birth rate, Biochemical pregnancy rate, Early pregnancy loss, Fetal miscarriage, Perinatal outcomes: preterm birth, birth weight, congenital malformation, perinatal mortality, Obstetric outcomes: hypertensive disorders of pregnancy, gestational diabetes, postpartum hemorrhage and cesarean section, Hormone levels measured on the day of insemination, mid-luteal phase and ovulation trigger (optional)—

Outcome results

None listed

Source: EU CTIS · Data processed: Mar 10, 2026